Interview with John Gebler at EBF 2016

We interviewed John Gebler, Director of Biopharm Business Development at Waters (USA), at the 9th EBF Open Meeting to find out about the current work Waters is actively involved in, particularly in the area of biotherapeutics. John describes what is happening in biologics/ADC development and the challenges that they face between the characterization and quantification of ADC’s. He also discusses the importance of communication and collaboration and how Waters is encouraging this.

Click here to view Water’s company profile.